Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123210902 | 12321090 | 2 | F | 2015 | 20160818 | 20160502 | 20160826 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00678 | WESTWARD | 46.66 | YR | F | Y | 62.60000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123210902 | 12321090 | 1 | PS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intravenous (not otherwise specified) | 65342 | 2 | G | |||||||||
| 123210902 | 12321090 | 2 | SS | HEPARIN | HEPARIN SODIUM | 1 | Unknown | 17037 | 5000 | IU | |||||||||
| 123210902 | 12321090 | 3 | SS | HEPARIN | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 17037 | 16 | IU/KG | /hr | ||||||||
| 123210902 | 12321090 | 4 | SS | HEPARIN | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 17037 | |||||||||||
| 123210902 | 12321090 | 5 | SS | KETAMINE | KETAMINE | 1 | Unknown | 74524 | |||||||||||
| 123210902 | 12321090 | 6 | SS | PHENYLEPHRINE | PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE | 1 | Unknown | 203826 | |||||||||||
| 123210902 | 12321090 | 7 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 62682 | |||||||||||
| 123210902 | 12321090 | 8 | SS | RUXOLITINIB | RUXOLITINIB | 1 | Oral | 0 | BID | ||||||||||
| 123210902 | 12321090 | 9 | SS | REGORAFENIB | REGORAFENIB | 1 | Oral | 0 | QID | ||||||||||
| 123210902 | 12321090 | 10 | SS | CEFTAROLINE | CEFTAROLINE | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | BID | ||||||||
| 123210902 | 12321090 | 11 | SS | CEFTAROLINE | CEFTAROLINE | 1 | Unknown | 0 | |||||||||||
| 123210902 | 12321090 | 12 | SS | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | |||||||||
| 123210902 | 12321090 | 13 | SS | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TID | ||||||||
| 123210902 | 12321090 | 14 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 1 | MG | |||||||||
| 123210902 | 12321090 | 15 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | .5 | MG | |||||||||
| 123210902 | 12321090 | 16 | SS | DIPRIVAN | PROPOFOL | 1 | Unknown | 0 | |||||||||||
| 123210902 | 12321090 | 17 | SS | DIPRIVAN | PROPOFOL | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 123210902 | 12321090 | 18 | SS | ATIVAN | LORAZEPAM | 1 | Oral | 0 | 1 | MG | Q6H | ||||||||
| 123210902 | 12321090 | 19 | SS | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 123210902 | 12321090 | 20 | SS | ROXICODONE | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 15 | MG | Q4H | ||||||||
| 123210902 | 12321090 | 21 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | 0 | 100 | UG | PATCH | /hr | |||||||
| 123210902 | 12321090 | 22 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | 0 | 50 | UG | PATCH | ||||||||
| 123210902 | 12321090 | 23 | SS | XANAX | ALPRAZOLAM | 1 | Unknown | 0 | |||||||||||
| 123210902 | 12321090 | 24 | SS | SUBLIMAZE | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 0 | 50 | UG | |||||||||
| 123210902 | 12321090 | 25 | SS | SUBLIMAZE | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 0 | 50 | UG | |||||||||
| 123210902 | 12321090 | 26 | SS | VERSED | MIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 123210902 | 12321090 | 27 | C | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | 0 | |||||||||||
| 123210902 | 12321090 | 28 | C | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | 0 | |||||||||||
| 123210902 | 12321090 | 29 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 123210902 | 12321090 | 30 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 0 | BID | ||||||||||
| 123210902 | 12321090 | 31 | C | CEFTAROLINE | CEFTAROLINE | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123210902 | 12321090 | 1 | Product used for unknown indication |
| 123210902 | 12321090 | 2 | Product used for unknown indication |
| 123210902 | 12321090 | 5 | Product used for unknown indication |
| 123210902 | 12321090 | 6 | Product used for unknown indication |
| 123210902 | 12321090 | 7 | Product used for unknown indication |
| 123210902 | 12321090 | 8 | Colorectal cancer metastatic |
| 123210902 | 12321090 | 9 | Colorectal cancer metastatic |
| 123210902 | 12321090 | 10 | Product used for unknown indication |
| 123210902 | 12321090 | 12 | Muscle spasms |
| 123210902 | 12321090 | 14 | Pain |
| 123210902 | 12321090 | 18 | Nausea |
| 123210902 | 12321090 | 19 | Vomiting |
| 123210902 | 12321090 | 20 | Breakthrough pain |
| 123210902 | 12321090 | 21 | Product used for unknown indication |
| 123210902 | 12321090 | 23 | Product used for unknown indication |
| 123210902 | 12321090 | 24 | Pain |
| 123210902 | 12321090 | 25 | Surgery |
| 123210902 | 12321090 | 26 | Surgery |
| 123210902 | 12321090 | 27 | Product used for unknown indication |
| 123210902 | 12321090 | 29 | Product used for unknown indication |
| 123210902 | 12321090 | 31 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123210902 | 12321090 | HO |
| 123210902 | 12321090 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123210902 | 12321090 | Colorectal cancer metastatic | |
| 123210902 | 12321090 | Condition aggravated | |
| 123210902 | 12321090 | Embolism | |
| 123210902 | 12321090 | Encephalopathy | |
| 123210902 | 12321090 | Oedema peripheral | |
| 123210902 | 12321090 | Retroperitoneal lymphadenopathy | |
| 123210902 | 12321090 | Venous occlusion | |
| 123210902 | 12321090 | Venous thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123210902 | 12321090 | 2 | 20150913 | 20150913 | 0 | |
| 123210902 | 12321090 | 3 | 20151001 | 20151002 | 0 | |
| 123210902 | 12321090 | 4 | 20151005 | 0 | ||
| 123210902 | 12321090 | 5 | 20150915 | 20150915 | 0 | |
| 123210902 | 12321090 | 6 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 7 | 20150912 | 20150912 | 0 | |
| 123210902 | 12321090 | 8 | 20150303 | 20150910 | 0 | |
| 123210902 | 12321090 | 9 | 20150303 | 20150910 | 0 | |
| 123210902 | 12321090 | 10 | 20150913 | 0 | ||
| 123210902 | 12321090 | 12 | 20150913 | 0 | ||
| 123210902 | 12321090 | 13 | 20150930 | 20151007 | 0 | |
| 123210902 | 12321090 | 14 | 20150915 | 0 | ||
| 123210902 | 12321090 | 15 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 16 | 20150915 | 0 | ||
| 123210902 | 12321090 | 17 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 18 | 20150930 | 20151007 | 0 | |
| 123210902 | 12321090 | 20 | 20151001 | 20151007 | 0 | |
| 123210902 | 12321090 | 21 | 20151001 | 20151007 | 0 | |
| 123210902 | 12321090 | 22 | 20151001 | 20151007 | 0 | |
| 123210902 | 12321090 | 23 | 20151005 | 0 | ||
| 123210902 | 12321090 | 24 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 25 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 26 | 20151005 | 20151005 | 0 | |
| 123210902 | 12321090 | 27 | 20150912 | 0 | ||
| 123210902 | 12321090 | 28 | 20150919 | 0 | ||
| 123210902 | 12321090 | 29 | 20150912 | 20150912 | 0 | |
| 123210902 | 12321090 | 30 | 20150912 | 20150912 | 0 | |
| 123210902 | 12321090 | 31 | 20150913 | 0 |